Ann: Emyria secures clinical-grade MDMA supply for Aust patients, page-12

Great thought-provoking comments here Scooty.

I appreciate reading a healthy post that pushes people to look and understand what they are investing in and why.

I've made it obvious that I am on the EMD train.

I've been big on EMD because of the RX5 and RX7 side of the company.

With the real world data also a huge strength of the company.

For me this MDMA news and aspect has been a happy side push.

I do take into consideration your comments regarding cash burn. My faith (maybe a fools wish) is with the big backers (twiggy, etc) staying on board and openly stating they will add cash when needed for capital raises.

Hope you continue to post, stay active with the community.

I appreciate reading and making myself reflect on why I'm holding.